Price $118.59 |
Market Cap
260.98B
|
Sector Health Care |
Div. Growth
5.90%
|
|
P/E
57.3
|
P/B
6.78
|
P/S
4.43
|
Dividend %
2.80%
|
|
P/CF
-
|
P/FCF
73.2
|
Op. Cash Flow
15.08M
|
FCF
1.4
|
|
Op. Margin
11.10%
|
Net Margin
5.20%
|
ROE
7.10%
|
ROI
20.90%
|
|
ROA
2.90%
|
EPS Growth
-81.20%
|
Current Ratio
1.5
|
Debt/Equity
62.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
